Report summary
- This page summarizes the 2025 sustainability report and ESG report PDF source for 易威生醫科技股份有限公司 (1799).
- The reporting period is 2025/01/01 to 2025/12/31, in the 生技醫療業 industry.
- third-party verification or assurance body information is not currently provided; this can be used to review report verification, assurance, and disclosure standards.
- Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.
Report details
- Company
- 易威生醫科技股份有限公司(1799)
- Reporting Year
- 2025
- Disclosure Period
- 2025/01/01 to 2025/12/31
- Industry
- 生技醫療業
- Third-party information
- third-party verification or assurance body information is not currently provided
- PDF source
- The original ESG report PDF can be downloaded or opened from this page
2025 ESG Metrics and Industry Comparison
Greenhouse Gas Emissions
- Scope 1 Emissions (Tons CO2e)
- 6.5
- Reporting Boundary:已完成母公司
- Verification:否
- Scope 2 Emissions (Tons CO2e)
- 16
- Reporting Boundary:已完成母公司
- Verification:否
- Scope 3 Emissions (Tons CO2e)
- 9.4
- Reporting Boundary:已完成母公司
- Verification:否
Energy Management
- Renewable Energy Share
- 0%
- Reporting Boundary:資料範圍涵蓋易威生醫科技股份有限公司新竹總公司(新竹市科學園區研發二路10號1樓)之能源使用情形,包括直接能源(柴油)及外購電力,不包含海外子公司。
- Verification:Not disclosed
- Ranked 8 among 18 companies in the same industry (percentile 0).
Water Management
- Water Use (Metric Tons)
- 809
- Reporting Boundary:本公司新竹總公司(新竹市科學園區研發二路10號1樓)營運據點之用水量,不包含海外子公司。
- Verification:Not disclosed
Board of Directors
- Board Seats (Including Independent Directors)
- 10
- Independent Director Seats
- 4
- Female Director Ratio
- 10%
- Ranked 91 among 96 companies in the same industry (percentile 3).
- Board Meeting Attendance Rate
- 92.5%
- Ranked 78 among 96 companies in the same industry (percentile 19).
- Independent Director Ratio
- 40%
- Ranked 59 among 96 companies in the same industry (percentile 36).
Source: Taiwan Stock Exchange / Taipei Exchange, Corporate ESG Disclosure Summary (2025), under the Open Government Data License, version 1.0. Open Government Data License, Version 1.0
How to use this report
- Compare how 易威生醫科技股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2025.
- Confirm the reporting period, third-party verification or assurance information, and downloadable ESG report PDF source.
- Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.
Reports from the Same Industry
-
Download report
大江生醫股份有限公司
2025 Sustainability Report
-
Download report
合一生技股份有限公司
2025 Sustainability Report
-
Download report
中天生物科技股份有限公司
2025 Sustainability Report
-
Download report
威力德生醫股份有限公司
2025 Sustainability Report
-
Download report
台耀化學股份有限公司
2025 Sustainability Report
-
Download report
東生華製藥股份有限公司
2025 Sustainability Report
-
Download report
台灣東洋藥品工業股份有限公司
2025 Sustainability Report
-
Download report
醫揚科技股份有限公司
2025 Sustainability Report
-
Download report
佳醫健康事業股份有限公司
2025 Sustainability Report
-
Download report
大學光學科技股份有限公司
2025 Sustainability Report
